Vice President, Biochemistry and Head of Early Discovery Projects
Parabilis Medicines
Early Discovery Projects Team at Parabilis Medicines leads the scientific strategy for novel biopharmaceutical programs, focusing on challenging intracellular targets. The VP drives portfolio direction, oversees hit discovery through hit‑to‑lead, and manages a team of biochemists and biophysicists while collaborating with AI, computational drug discovery, and biology groups.